CVS Settles DOJ Opioid Case for $315 Million: Here’s What It Means for the Stock

CVS Health (CVS:NYSE) agreed on Tuesday, October 13, to pay $315 million to settle a Justice Department lawsuit over opioid prescriptions, Reuters reported. The government alleged that CVS pharmacies filled invalid prescriptions for opioids and other controlled substances from October 2013 through December 2025, then billed Medicare and other federal programs for many of them.